01593nam a2200241   45000010005000000100015000051000041000201010008000612000160000692100082002292150023003112250037003343000131003713300622005026060022011246060034011466060033011806060022012136060012012356060024012477100069012718520011013405856  a9291680877  a20010326d1999       y0pory50      ba  aeng  aReport on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugsfEuropean Monitoring Centre for Drugs and Drug Addiction  aLuxembourgcOffice for Official Publication of the European Communitiesd1999  a114 p.cil.d21 cm  aImplemention of the joint action  aInformação sobre European Monitoring Centre for Drugs and Drug Addiction pode ser encontrada no site: https:/www.emcdda.org  aReport on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs. Council decision of 13 September 1999 defining 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties. Europol-EMCDDA progress report on 4-MTA in accordance with article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Review of the pharmacotoxicological data on 4-MTA. Public health risks of 4-MTA: epidemiological evidence. Sociological and criminological evidence on the risks of 4-MTA.  aDROGAS ILÍCITAS  aSUBSTÂNCIAS PSICOTRÓPICAS  aCOOPERAÇÃO INTERNACIONAL  aSAÚDE PÚBLICA  aEUROPOL  aCONSELHO DA  EUROPA  aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA  jDRO319